DK256488D0 - Immunmodulerende farmaceutisk praeparat - Google Patents

Immunmodulerende farmaceutisk praeparat

Info

Publication number
DK256488D0
DK256488D0 DK256488A DK256488A DK256488D0 DK 256488 D0 DK256488 D0 DK 256488D0 DK 256488 A DK256488 A DK 256488A DK 256488 A DK256488 A DK 256488A DK 256488 D0 DK256488 D0 DK 256488D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
modulating pharmaceutical
immuno modulating
immuno
preparation
Prior art date
Application number
DK256488A
Other languages
English (en)
Other versions
DK256488A (da
Inventor
Barbara J Dalton
Robert C Rees
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of DK256488A publication Critical patent/DK256488A/da
Publication of DK256488D0 publication Critical patent/DK256488D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK256488A 1986-09-10 1988-05-10 Immunmodulerende farmaceutisk praeparat DK256488D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/905,825 US4803072A (en) 1986-09-10 1986-09-10 Immunomodulation
PCT/US1987/002218 WO1988001875A1 (en) 1986-09-10 1987-09-02 Immunomodulation

Publications (2)

Publication Number Publication Date
DK256488A DK256488A (da) 1988-05-10
DK256488D0 true DK256488D0 (da) 1988-05-10

Family

ID=25421543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK256488A DK256488D0 (da) 1986-09-10 1988-05-10 Immunmodulerende farmaceutisk praeparat

Country Status (5)

Country Link
US (1) US4803072A (da)
AU (1) AU7915187A (da)
DK (1) DK256488D0 (da)
GR (1) GR871388B (da)
WO (1) WO1988001875A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US5851991A (en) * 1987-08-31 1998-12-22 The Regents Of The University Of California Therapeutic use of the retinoblastoma susceptibility gene product
US7105156B1 (en) 1987-09-17 2006-09-12 The Regents Of The University Of California Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
DK425789A (da) * 1988-08-31 1990-03-01 Smithkline Beecham Corp Vaccinale polypeptider
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US5766601A (en) * 1990-08-08 1998-06-16 University Of Massachusetts Medical Center Cross-reactive influenza a immunization
DE69123252T2 (de) * 1990-08-08 1997-03-13 Univ Massachusetts Medical Kreuzreaktive immunisierung gegen influenza
US5342612A (en) * 1991-12-20 1994-08-30 American Cyanamid Company Compositions for the treatment of mammalian diseases
US5686268A (en) * 1992-06-19 1997-11-11 Pfizer Inc. Fused proteins
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
US7135458B1 (en) * 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5610075A (en) * 1995-01-17 1997-03-11 Stahl-Rees; Marianne Competitive electrochemiluminescence assays for endotoxins using a ruthenium label
US6610838B1 (en) 1997-09-10 2003-08-26 Symbicom Aktiebolag P13 antigens from Borrelia
US7198920B1 (en) * 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
ES2551164T3 (es) * 2000-03-24 2015-11-16 Biosphere Medical, Inc. Microesferas para embolización activa
US7229623B1 (en) * 2000-08-03 2007-06-12 Corixa Corporation Her-2/neu fusion proteins
EP1687017B1 (en) 2003-10-24 2013-03-06 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT360343B (de) * 1979-03-21 1980-01-12 Voest Alpine Ag Schrottpresse
AR241713A1 (es) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.

Also Published As

Publication number Publication date
DK256488A (da) 1988-05-10
WO1988001875A1 (en) 1988-03-24
US4803072A (en) 1989-02-07
AU7915187A (en) 1988-04-07
GR871388B (en) 1988-01-12

Similar Documents

Publication Publication Date Title
DK256488A (da) Immunmodulerende farmaceutisk praeparat
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK89090A (da) Farmaceutisk praeparat
DK546886D0 (da) Farmaceutisk praeparat
DK489189D0 (da) Farmaceutisk praeparat
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
DK705488A (da) Farmaceutisk praeparat
DK413987D0 (da) Farmaceutiske praeparater
DK10087D0 (da) Praeparat
DK652787D0 (da) Farmaceutiske praeparater
DK603988D0 (da) Farmaceutisk praeparat
DK244488D0 (da) Efterskummende praeparat
DK255787D0 (da) Praeparat
DK336489D0 (da) Farmaceutisk praeparat
DK447887D0 (da) Frysetoerrede farmaceutiske praeparater
DK139388A (da) Farmaceutisk praeparat
DK276288A (da) Farmaceutisk praeparat
DK8188A (da) Veterinaert praeparat
DK30788A (da) Co-vaccinationspraeparat
DK138888D0 (da) Farmaceutisk praeparat
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK428287A (da) Nasalt farmaceutisk praeparat
SE8603912D0 (sv) Farmaceutisk beredning
SE8602975D0 (sv) Farmaceutisk beredning
DK638889D0 (da) Farmaceutisk kombinationspraeparat

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment